TY - JOUR
T1 - Guidelines for the immunization of adolescents and adults living in Colombia. Update document, 2016
AU - Gómez Muñoz, Juan Manuel
AU - Gómez Rincón, Julio César
AU - Alí Munive, Abraham
AU - Cano Gutierrez, Carlos A.
AU - Coral Alvarado, Paola X.
AU - Coronell Rodríguez, Wilfrido
AU - Cortés Luna, Jorge
AU - Duarte Romero, Mónica
AU - Londoño Palacio, Natalia
AU - Maldonado Chaya, Ivette
AU - Palacio Eastman, Ana Cristina
AU - Porras Ramirez, Alexandra
N1 - Publisher Copyright:
© 2016 ACIN
PY - 2016/10/1
Y1 - 2016/10/1
N2 - This document was prepared by a multi-disciplinary panel of experts who have been selected by the Asociación Colombiana de Infectologia (ACIN) to revise and update previous recommendations (by our group) for the immunization of adolescents and adult population and those older than 60 years of age. For the latter group, we have chosen to move forward, like many others, and immunize them at that age because of the particular burden of disease due to respiratory conditions, and other factors strictly related to Latin America and Colombian socio-economic conditions. This edition replaces in part, updates or ads to previous recommendations published in INFECTIO, May 2012. The guidelines are intended to assist those caring for these patients, and emphasizes on the elderly, the immunocompromissed and on those who suffer from several co-morbidities. The contents of the guidelines could seem incomplete at some point; nevertheless, they were purposefully thought as such to embrace on major changes in new vaccines or new dosing regimens. It is included for the first time the use of cuadri-valent vaccines against influenza. The use of herpes zoster vaccine is discussed and special care is placed in the phrasing for the reader so he (she) understands the «when and why» of vaccine administration against Streptococcus pneumoniae. With pneumococcal vaccines, timing of administration may vary according to age, co-morbidities and in those previously vaccinated with the 23-polyvalent polysaccharide vaccine. There are new recommendations for the vaccination against yellow fever and dengue and we welcome the new nona-valent vaccine against the human papilloma virus.
AB - This document was prepared by a multi-disciplinary panel of experts who have been selected by the Asociación Colombiana de Infectologia (ACIN) to revise and update previous recommendations (by our group) for the immunization of adolescents and adult population and those older than 60 years of age. For the latter group, we have chosen to move forward, like many others, and immunize them at that age because of the particular burden of disease due to respiratory conditions, and other factors strictly related to Latin America and Colombian socio-economic conditions. This edition replaces in part, updates or ads to previous recommendations published in INFECTIO, May 2012. The guidelines are intended to assist those caring for these patients, and emphasizes on the elderly, the immunocompromissed and on those who suffer from several co-morbidities. The contents of the guidelines could seem incomplete at some point; nevertheless, they were purposefully thought as such to embrace on major changes in new vaccines or new dosing regimens. It is included for the first time the use of cuadri-valent vaccines against influenza. The use of herpes zoster vaccine is discussed and special care is placed in the phrasing for the reader so he (she) understands the «when and why» of vaccine administration against Streptococcus pneumoniae. With pneumococcal vaccines, timing of administration may vary according to age, co-morbidities and in those previously vaccinated with the 23-polyvalent polysaccharide vaccine. There are new recommendations for the vaccination against yellow fever and dengue and we welcome the new nona-valent vaccine against the human papilloma virus.
KW - Dengue
KW - Evidence based medicine
KW - Human immunodeficiency virus
KW - Human papilloma virus
KW - Influenza
KW - Vaccination guidelines for Colombia
KW - Yellow fever
UR - http://www.scopus.com/inward/record.url?scp=85006049802&partnerID=8YFLogxK
U2 - 10.1016/j.infect.2016.08.001
DO - 10.1016/j.infect.2016.08.001
M3 - Article
AN - SCOPUS:85006049802
SN - 0123-9392
VL - 20
SP - 192
EP - 210
JO - Infectio
JF - Infectio
IS - 4
ER -